🇺🇸 exenatide (Byetta) in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 1 report (10%)
  2. Asthenia — 1 report (10%)
  3. Atrial Fibrillation — 1 report (10%)
  4. Dizziness — 1 report (10%)
  5. Fatigue — 1 report (10%)
  6. Gastric Ulcer — 1 report (10%)
  7. Intestinal Ulcer — 1 report (10%)
  8. Pain In Extremity — 1 report (10%)
  9. Palpitations — 1 report (10%)
  10. Tenderness — 1 report (10%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is exenatide (Byetta) approved in United States?

exenatide (Byetta) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for exenatide (Byetta) in United States?

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the originator. The local marketing authorisation holder may differ — check the official source linked above.